Atlas Trials

Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous Administration

Clinical trial NCT01217645 · COMPLETED

Trial details

NCT number
NCT01217645
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2010-09-01
Primary completion
2010-10-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.